Stock Earnings

Question 1

Catalyst Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Catalyst Pharmaceuticals Inc의 총 자산은 $851이며, 순profit입니다.

Question 2

CPRX의 주요 재무 비율은 무엇인가요?

Accepted Answer

Catalyst Pharmaceuticals Inc의 유동비율은 6.91이고, 순이익률은 33.19, 주당 매출은 $3.92입니다.

Question 3

Catalyst Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Catalyst Pharmaceuticals Inc largest revenue segment is Drug Products, at a revenue of 491,734,000 in the most earnings release.For geography, United States is the primary market for Catalyst Pharmaceuticals Inc, at a revenue of 491,734,000.

Question 4

Catalyst Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Catalyst Pharmaceuticals Inc의 순profit은 $163입니다.

Question 5

Catalyst Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Catalyst Pharmaceuticals Inc의 부채는 123입니다.

Question 6

Catalyst Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Catalyst Pharmaceuticals Inc의 총 발행 주식은 120.87주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	558	491	398	214	140	119
Revenue Growth (YoY)	28.99%	23%	86%	53%	18%	17%
Cost of Revenue	79	68	51	34	21	17
Gross Profit	479	422	346	179	118	102
Selling, General & Admin	182	177	133	58	49	44
Research & Development	15	12	93	19	16	16
Operating Expenses	235	227	259	78	66	60
Other Non Operating Income (Expenses)	28	21	7	2	0	0
Pretax Income	271	216	94	104	52	41
Income Tax Expense	63	52	23	21	13	-33
Net Income	208	163	71	83	39	75
Net Income Growth	206%	130%	-14%	112.99%	-48%	142%
Shares Outstanding (Diluted)	127.54	124.94	113.75	111.4	107.8	106.2
Shares Change (YoY)	2%	10%	2%	3%	2%	0%
EPS (Diluted)	1.64	1.31	0.62	0.75	0.37	0.71
EPS Growth	210%	109%	-16%	103%	-48%	137%
Free Cash Flow	274	239	143	116	59	45
Free Cash Flow Per Share	2.14	1.91	1.25	1.04	0.54	0.42
Gross Margin	85.84%	85.94%	86.93%	83.64%	84.28%	85.71%
Operating Margin	43.54%	39.71%	21.6%	47.19%	37.14%	34.45%
Profit Margin	37.27%	33.19%	17.83%	38.78%	27.85%	63.02%
Free Cash Flow Margin	49.1%	48.67%	35.92%	54.2%	42.14%	37.81%
EBITDA	280	232	118	102	52	41
EBITDA Margin	50.17%	47.25%	29.64%	47.66%	37.14%	34.45%
D&A For EBITDA	37	37	32	1	0	0
EBIT	243	195	86	101	52	41
EBIT Margin	43.54%	39.71%	21.6%	47.19%	37.14%	34.45%
Effective Tax Rate	23.24%	24.07%	24.46%	20.19%	25%	-80.48%

Catalyst Pharmaceuticals Inc (CPRX) Price

CPRX Stock Price Chart

CPRX Income

Follow-Up Questions